North American vasovagal pacemaker study: Study design and organization

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 3 II, 1997, Pages 844-848

  Sheldon, Robert S ^a   Gent, Michael ^b   Roberts, Robin S ^b   Connolly, Stuart J ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Pacemaker; Randomized trial; Rate drop sensing; Syncope; Tilt table test; Vasovagal

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART PACING; HUMAN; MULTICENTER STUDY; PACEMAKER; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYNCOPE; TILTING; TREATMENT OUTCOME;

BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; EQUIPMENT DESIGN; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MEDICAL RECORDS; NORTH AMERICA; PACEMAKER, ARTIFICIAL; PATIENT SELECTION; PILOT PROJECTS; RECURRENCE; RESEARCH DESIGN; RISK FACTORS; SAMPLE SIZE; SYNCOPE; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 0030964978     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb03919.x     Document Type: Article

References (10)

1. Benditt DG, Petersen M, Lurie KG, et al. Cardiac pacing for the prevention of recurrent vasovagal syncope. Ann Intern Med 1995; 122:204-209.
2. Sra JS, Jazayeri MR, Avitall BA, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328:1085-1090.
3. Fitzpatrick A, Theodorakis G, Ahmed R, et al. Dual chamber pacing aborts vasovagal syncope induced by head-up 60° tilt. PACE 1991; 14:13-19.
4. Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur JCPE 1993; 1:36-41.
5. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, et al. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71:274-281.
6. Sheldon R, Rose S, Flanagan P, et al. Risk factors for syncope recurrence after a positive tilt table test in patients with syncope. Circulation 1996; 93: 973-981.
7. Malik P, Koshman ML, Sheldon RS. Time to first syncopal spell following tilt table test predicts number of recurrent spells. J Am Coll Cardiol 1997 (In press).
8. Rose S, Koshman ML, McDonald S, et al. Health-related quality of life in patients with neuromediated syncope. (abstract) Can J Cardiol 1996; 12:131E.
9. Linzer M, Pontinen M, Gold DT, et al. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol 1991; 44:1037-1043.
10. Linzer M, Gold DT, Pontinen M, et al. Recurrent syncope as a chronic disease: Preliminary validation of a disease-specific measure of functional impairment. J Gen Int Med 1994; 9:181-186.